Skip to content

mHealth Family Self-Management

mHealth Family Self-Management Intervention for Parents of Transplanted Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03533049
Acronym
myFAMI
Enrollment
67
Registered
2018-05-22
Start date
2018-10-01
Completion date
2020-05-01
Last updated
2020-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric ALL, Transplantation

Brief summary

This innovative research will address a gap in the literature involving the evaluation of the impact of an individualized family-centered mHealth application to enhance daily post-discharge communication following pediatric transplant. This proposal lays the foundation for future research with myFAMI (self-management intervention) at multiple pediatric transplant centers and builds the science from which to consider post discharge monitoring and decrease cost of care in other pediatric chronic illness populations.

Interventions

OTHERmyFAMI

Patients who are assigned to the myFAMI group will also have the smartphone application downloaded onto either the family member's smartphone or a study-provided smartphone. Following discharge from the hospital, participants will use the smartphone application to answer nine daily questions regarding tracking family coping, transplant symptoms, family management of child transplant symptoms, and family-management difficulty with medication and follow-up regimen daily for the first 30 days following discharge.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Medical College of Wisconsin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
No minimum to 100 Years
Healthy volunteers
No

Inclusion criteria

Pediatric patients: 1. Has undergone a heart, kidney, or liver transplant being discharged home from the hospital 2. Has two eligible family members available to answer questions about the patient Family members will be eligible for participation upon meeting the following inclusion criteria: 1. is English speaking (to date the instruments being used have been validated for English speaking participants only) 2. is 18 years of age or older 3. has a pediatric family member (\< 18 years old) who has undergone a heart, kidney, or liver transplant being discharged home from the hospital.

Exclusion criteria

for the family members are: 1. presence of significant communication or cognitive impairment that would preclude completion of questionnaires based on self-report; or 2. the pediatric family member has experienced a previous transplant based on self report. Participants unable to speak and read English will be excluded due to the lack of resources to develop the app and communicate via FaceTime in different languages. We will recruit family members from three types of transplant populations to allow for sufficient sample in a limited time frame for this complex pediatric surgery and high-risk population. \-

Design outcomes

Primary

MeasureTime frameDescription
Improve family coping30 daysPrimary family member receiving myFAMI compared to the primary family member receiving standard post-discharge care will have improved post-discharge coping (primary outcome). Coping will be measured using the post-discharge coping difficulty scale. Post Discharge Coping Difficulty Scale (PDCDS), 10-item measure, Scale 0-10, Measures parental and family member difficulty coping with stress, recovery, self-care and management, support, and confidence, α= .84

Secondary

MeasureTime frameDescription
Decrease healthcare resources30 daysPrimary family member receiving myFAMI compared to the primary family member receiving standard post-discharge care will have decreased use of healthcare resources defined as number of emergency department visits and number or readmissions to the hospital.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026